Author Archive

Introducing our new Associate Editors Professor Jons Hilborn and Professor Fu-Jian Xu

 

In 2001 Jöns Hilborn was appointed to the head of the Polymer Chemistry program at the Department of Chemistry at Uppsala University in Sweden. He has extensive management experience from life science industry, start-up companies and coordination of European projects.

His research interests are in the design, synthesis and preparation of polymers and specifically materials for tissue scaffolds and as delivery vehicles. His group especially focuses on hydrogel matrices that act on endogenous cells to regenerate tissue. His laboratory combines chemistry, biology, engineering with medicine to bring their research findings from the lab bench to the clinic and commercial applications. He served as president of “Tissue Engineering and Regenerative Medicine International Society” (TERMIS), of which he was a founding member. 

Read some of Jöns recent research in Biomaterials Science: 

Control of growth factor binding and release in bisphosphonate functionalized hydrogels guides rapid differentiation of precursor cells in vitro
Sujit Kootala, Yu Zhang, Sara Ghalib, Vladimir Tolmachev, Jöns Hilborn and Dmitri A. Ossipov
Biomater. Sci., 2016,4, 250-254

In situ forming interpenetrating hydrogels of hyaluronic acid hybridized with iron oxide nanoparticles
Malihe Kheirabadi, Liyang Shi, Reza Bagheri, Kourosh Kabiri, Jöns Hilborn and Dmitri A. Ossipov
Biomater. Sci., 2015,3, 1466-1474

Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery
Oommen P. Varghese, Jianping Liu, Karthi Sundaram, Jöns Hilborn and Oommen P. Oommen
Biomater. Sci., 2016,4, 1310-1313

 

Fu-Jian Xu is a Professor and the executive director of Beijing Laboratory of Biomedical Materials at Beijing University of Chemical Technology. His research interests include functional materials for drug/gene delivery, natural polysaccharides for wound healing, and surface modification for biomedical applications including antibacterial, antifouling, and biocompatible surfaces.

He was the recipient of the Top Young Talents of National Special Support Program (2012), National Science Fund for Distinguished Young Scholars of China (NSFC, 2013), Cheung Kong Distinguished Professor (Ministry of Education of China, 2014), and Distinguished Young Scientists Program of Beijing Universities (2018).

Learn more about Fujian by reading some of his research articles below:

Phthalocyanine functionalized poly(glycidyl methacrylate) nano-assemblies for photodynamic inactivation of bacteria
Wei Tong, Yanhua Xiong, Shun Duan, Xiaokang Ding and Fu-Jian Xu
Biomater. Sci., 2019, Advance Article

Multifunctional hybrids with versatile types of nanoparticles via self-assembly for complementary tumor therapy
Shun Duan, Jia Li, Nana Zhao and Fu-Jian Xu
Nanoscale, 2018, 10, 7649-7657

High-performance cationic polyrotaxanes terminated with polypeptides as promising nucleic acid delivery systems
Hai-Qing Song, Yu Qi, Rui-Quan Li, Gang Cheng, Nana Zhao and Fu-Jian Xu
Polym. Chem., 2018, 9, 2281-2289

PGMA-based gene carriers with lipid molecules
Chen Xu, Bingran Yu, Hao Hu, Muhammad Naeem Nizam, Wei Yuan, Jie Ma and Fu-Jian Xu
Biomater. Sci., 2016, 4, 1233-1243

Biomolecule-functionalized polymer brushes
Hui Jiang and Fu-Jian Xu
Chem. Soc. Rev., 2013, 42, 3394-3426

 

All these articles are currently FREE to read until the 31st May!

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

TERMIS EU 2019

Tissue Engineering Therapies: From Concept to Clinical Translation & Commercialisation

The TERMIS-EU 2019 meeting is to be held from the 27th to the 31st of May 2019 in Rhodes, Greece. The theme of the meeting is ‘Tissue Engineering Therapies: From concept to clinical translation and commercialisation’.

The programme of the TERMIS EU 2019 will include specific workshops and symposia in tissue engineering and regenerative medicine tools, technologies and discoveries; clinical trials; regulatory approval of new devices; scaling up; commercialisation; career development of young investigators; women leadership and representation; education; and outreach.

Standard registration is open throughout February.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)